Occupational Therapists in Arab, AL Accepting Medicare
6 Occupational Therapists found. Showing 1 - 6
 Kelley Pacillo, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1412 N Brindlee Mountain Pkwy, Arab, AL 35016 Phone: 256-931-2013 Fax: 256-931-2014 |
Ginger Williams Cavender Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 235 3rd St Se, Arab, AL 35016 Phone: 256-586-3111 |
Jennifer Williams King, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 235 3rd St Se, Arab, AL 35016 Phone: 256-586-3111 |
Sarah Mooney Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1510 N Brindlee Mountain Pkwy, Arab, AL 35016 Phone: 256-931-2013 Fax: 256-931-2014 |
Mrs. Laura Richey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1950 Friendship Rd, Arab, AL 35016 Phone: 256-931-6088 Fax: 256-931-6088 |
 Occupational Therapy Services, Inc. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 261 S Main St, Arab, AL 35016 Phone: 256-931-3711 Fax: 256-931-3711 |
News Archive
American Health Network live using eClinicalWorks CCMR for population health management
eClinicalWorks®, a leader in ambulatory healthcare IT solutions, today announced American Health Network (AHN) is live using eClinicalWorks Care Coordination Medical Record® (CCMR) for population health management to manage three Accountable Care Organizations (ACOs) - American Health Network of Ohio Care Organization, Franciscan AHN ACO and Indiana Care Organization.
Mosquito control using special bacteria infected mosquitoes approved by the EPA
The Environmental Protection Agency has now approved the use of special mosquitoes that have been infected with bacteria called Wolbachia for eradication of mosquitoes in 20 states and District of Columbia. This approach is known as the use of "biopesticide". Now mosquitoes that spread viral illnesses like Dengue, Chikungunya, Zika etc. would be controlled effectively.
Phase 3 AVERROES clinical trial of apixaban for atrial fibrillation closes early due to clear evidence of efficacy
Bristol-Myers Squibb Company and Pfizer today announced that the companies have agreed to stop the Phase 3 AVERROES clinical trial of apixaban in patients with atrial fibrillation. The study will be stopped early because a predefined interim analysis by the independent Data Monitoring Committee (DMC) revealed clear evidence of a clinically important reduction in stroke and systemic embolism in patients with atrial fibrillation considered intolerant of or unsuitable for vitamin K antagonist therapy who received apixaban as compared to aspirin.
Roundup: Ariz. examines complaints of prisoners' medical health care; Calif. settles suit on kids' mental health services
To stave off a lawsuit, Arizona's Department of Corrections has agreed to investigate scores of complaints by inmates that they are routinely denied medical care for weeks or months even for severe, life-threatening conditions. Inmates who have lost sight, had body parts amputated or been severely disfigured, among other gruesome examples, say proper medical care could have prevented needless suffering.
UC Berkeley receives $16.5 million to support three research centers to examine children's health
Researchers at the University of California, Berkeley's School of Public Health are getting $16.5 million to support three research centers as part of a federal initiative to examine the environmental factors influencing children's health.
› Verified 9 days ago
Optometrists
Occupational Therapists
Chiropractors
Speech-Language Pathologists
Physical Therapists